Abstract:In sheep infected with bovine leukemia virus (BLV), transcription of structural, enzymatic, and accessory genes is silenced. However, the BLV provirus transcribes a series of non-coding RNAs that remain undetected by the host immune response. Specifically, three RNAs (AS1-L, AS1-S, and AS2) are consistently expressed from the antisense strand, originating from transcriptional initiation at the 3'-Long Terminal Repeat (LTR). To investigate the role of these non-coding RNAs in viral replication and pathogenesis, a reverse genetics approach was devised, capitalizing on a mechanistic disparity in transcription initiation between the 5' and 3' promoters. A two-nucleotide mutation (GG>TA) in the TFIIB-recognition element (BRE) impaired antisense transcription originating from the 3'-LTR. In the context of the provirus, this 2bp mutation significantly diminished the expression of antisense RNAs, while not notably affecting sense transcription. When inoculated to sheep, the mutated provirus was infectious but exhibited reduced replication levels, shedding light on the role of antisense transcription in vivo. In comparison to lymphoid organs in sheep infected with a wild-type (WT) provirus, the mutant demonstrated alterations in both the spatial distribution and rates of cell proliferation in the lymph nodes and the spleen. Analysis through RNA sequencing and RT-qPCR unveiled an upregulation of the Hmcn1/ hemicentin-1 gene in B-lymphocytes from sheep infected with the mutated provirus. Further examination via confocal microscopy and immunohistochemistry revealed an increase in the amount of hemicentin-1 protein encoded by Hmcn1 in peripheral blood mononuclear cells (PBMCs) and lymphoid organs of sheep infected with the mutant. RNA interference targeting Hmcn1 expression impacted the migration of ovine kidney (OVK) cells in vitro . In contrast to the WT, the mutated provirus showed reduced oncogenicity when inoculated into sheep. Collectively, this study underscores the essential role of antisense transcription in BLV replication and pathogenicity. These findings may offer valuable insights into understanding the relevance of antisense transcription in the context of human T-cell leukemia virus (HTLV-1). In sheep infected with bovine leukemia virus (BLV), the transcription of genes encoding viral proteins is silenced. However, the virus constitutively produces long non-coding RNAs from the opposite strand of the integrated genome. To comprehend their role, we used reverse genetics to alter the BLV sequence, reducing the production of these antisense RNAs. When inoculated to sheep, this modified virus was infectious but could not replicate as well. Compared to the original strain, the number of mutated viruses was reduced in the peripheral blood and the lymphoid organs. Gene expression in B-cells from sheep infected with the mutated virus was altered, particularly affecting the Hmcn1 gene, which is involved in cell migration. Importantly, the modified virus did not cause leukemia in sheep, indicating the involvement of antisense RNAs in effective cancer development. In summary, our study underscores the significance of these antisense RNAs in the ability of the virus to replicate and induce illness. This understanding may offer insights into similar mechanisms in viruses affecting humans such as HTLV-1.

The BLV-miRNAs pathway of BLV inhibits the expression of Lactoferrin, Lactoperoxidase, Alpha-lactalbumin and Beta-lactoglobulin proteins

Characterization of mRNA Signature in Milk Small Extracellular Vesicles from Cattle Infected with Bovine Leukemia Virus

Peripheral Blood Mononuclear Cell Transcriptome of Dairy Cows Naturally Infected with Bovine Leukemia Virus

The bovine leukemia virus infection prolongs immunosuppression in dairy cows during the periparturient period by sustaining higher expression of immunological checkpoints in T cells

Bovine leukemia virus reduces anti‐viral cytokine activities and NK cytotoxicity by inducing TGF‐β secretion from regulatory T cells

Analysis of Differentially Expressed Micrornas in Bovine Mammary Epithelial Cells Treated with Lipoteichoic Acid.

Increased expression of the regulatory T cell-associated marker CTLA-4 in bovine leukemia virus infection

Up-regulated lncRNA CYLD as a ceRNA of miR-2383 facilitates bovine viral diarrhea virus replication by promoting CYLD expression to counteract RIG-I-mediated type-I IFN production

Effects of combined cytotoxic T-lymphocyte antigen 4 and programed death 1 ligand-receptor blockade on interferon-gamma production in bovine leukemia virus-infected cattle

The Potential Roles of Host Cell miRNAs in Fine-Tuning Bovine Coronavirus (BCoV) Molecular Pathogenesis, Tissue Tropism, and Immune Regulation

Reduction of antisense transcription affects bovine leukemia virus replication and oncogenesis

Exploration of microRNA Biomarkers in Blood Small Extracellular Vesicles for Enzootic Bovine Leukosis

Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs

Efficacy of physical and chemical treatments on the inactivation of bovine leukosis virus present in milk

IFN-τ Mediated Control of Bovine Major Histocompatibility Complex Class I Expression and Function Via the Regulation of Bta-Mir-148b/152 in Bovine Endometrial Epithelial Cells

Potential Risk Factors Associated with Infection with Bovine Leukaemia Virus in Dairy and Beef Cattle in Taiwan

Inhibition of protein kinase C results in decreased expression of bovine leukemia virus

Bioinformatics analysis of microRNA and putative target genes in bovine mammary tissue infected with Streptococcus uberis

Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line.

Milk Small Extracellular Vesicles-derived miRNAs Restrict Porcine Epidemic Diarrhea Virus Infectivity

Identification of bovine leukemia virus tax function associated with host cell transcription, signaling, stress response and immune response pathway by microarray-based gene expression analysis